Health
Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44000 volunteers – Canada.com
Pfizer Inc and BioNTech SE have proposed to the U.S Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial…
Pfizer Inc and BioNTech SE have proposed to the U.S Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to about 44,000 participants, the companies said on Saturday.
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
The proposed expansion would allow the companies to enroll people as young as 16 and people with chronic, stable HIV, hepatitis C and hepat…
-
Business22 hours agoBetashares reveals its 3 fastest-rising ASX ETFs of 2025 so far
-
Noosa News19 hours agoBega sells peanut processing plants at Kingaroy and Tolga to family business
-
Noosa News19 hours agoBrisbane news LIVE updates: Queensland Police Commissioner Steve Gollschewski back on job after cancer treatment | Thief steals and crashes hearse
-
General17 hours agoStewards placed hundreds of bets on Tasmanian races, integrity investigation finds